Zhanguo Li

Peking University - Department of Rheumatology and Immunology

Beijing

China

SCHOLARLY PAPERS

6

DOWNLOADS

244

TOTAL CITATIONS

0

Scholarly Papers (6)

1.

Impact of Environment At Early-Life On Rheumatoid Arthritis Risk: Results from the China Kadoorie Biobank

Number of pages: 26 Posted: 12 Feb 2024
Peking University - Department of Rheumatology and Immunology, Tsinghua University - Vanke School of Public Health, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Epidemiology and Biostatistics, Tsinghua University - Vanke School of Public Health, Peking University - Department of Rheumatology and Immunology and Peking University - Department of Rheumatology and Immunology
Downloads 49 (850,722)

Abstract:

Loading...

rheumatoid arthritis, environment, risk factor

2.

A Shifted Composition and Dysbiosis of Urinary Microbiota in Rheumatoid Arthritis: A Case-Control Study

Number of pages: 38 Posted: 12 Aug 2021
Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, TinyGene Bio-Tech (shanghai) Co.Ltd, TinyGene Bio-Tech (shanghai) Co.Ltd, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, The People’s Hospital of Xin Jiang Uygur Autonomous Region - Department of Rheumatology and Immunology, Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Peking University - Department of Rheumatology and Immunology and Peking University - Department of Rheumatology and Immunology
Downloads 47 (867,032)

Abstract:

Loading...

3.

SARS-CoV-2 Omicron BA.5.2/BF.7 Infection Aggravated Systemic Lupus Erythematosus in the First Infections Wave in China in November 2022: A Nationwide Large-Scale Population-Based Study

Number of pages: 32 Posted: 03 Apr 2024
Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, Nanjing Audit University, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology, Peking University - Department of Rheumatology and Immunology and Peking University - Department of Rheumatology and Immunology
Downloads 42 (910,335)

Abstract:

Loading...

4.

Clinical Remission of Rheumatoid Arthritis in a Multicenter Real-World Study in Asia-Pacific Region

Number of pages: 25 Posted: 29 Mar 2021
Peking University People's Hospital - Department of Rheumatology and Immunology, Peking University People's Hospital - Department of Rheumatology and Immunology, Peking University Shenzhen Hospital - Department of Rheumatology and Immunology, Al-Amiri Hospital - Rheumatology Unit, National University of Singapore (NUS) - Department of Medicine, Bangabandhu Sheikh Mujib Medical University - Department of Rheumatology, University of Indonesia (UI), Faculty of Medicine, Cipto Mangunkusumo National Hospital, Department of Internal Medicine, Brawijaya University - Saiful Anwar Hospital, Rheumatology Division, Keio University - Division of Rheumatology, University of Tokyo Graduate School of Medicine - Department of Allergy and Rheumatology, Bach Mai Hospital - Department of Rheumatology, Vedanta Institute of Medical Sciences and VS Hospital, Tan Tock Seng Hospital - Department of Rheumatology, Allergy and Immunology, Mahidol University - Division of Rheumatology, Patan Academy of Health Sciences - Department of Internal Medicine, Patan Academy of Health Sciences - Department of Internal Medicine, Phramongkutklao College of Medicine - Division of Rheumatology, Mahidol University - Ramathibodi Hospital, Division of Allergy, Immumology, and Rheumatology, Peking University - Department of Epidemiology and Biostatistics, Harvard University - Department of Biostatistics, The University of Hong Kong - Division of Rheumatology, Subang Jaya Medical Centre - Department of Medicine, Peking University - Department of Rheumatology and Immunology and Independent
Downloads 41 (919,518)

Abstract:

Loading...

5.

A Randomized, Double-Blind, Phase III Study to Compare the Efficacy and Safety of GB242 and Infliximab When Administered with Methotrexate in Patients with Active Moderate to Severe Rheumatoid Arthritis

Number of pages: 33 Posted: 31 Mar 2021
Peking University - Department of Rheumatology and Immunology, Zhengzhou University - First Affiliated Hospital, Xuzhou General Hospital -Department of Rheumatology and Immunology, First Hospital of Qiqihar, Jiujiang No.1 People's Hospital - Department of Rheumatology and Immunology, Xuzhou Medical University, Shanxi Medical University - First Hospital, The People’s Hospital of Xin Jiang Uygur Autonomous Region - Department of Rheumatology and Immunology, Bengbu Medical College - First Affiliated Hospital, Zaozhuang Municipal Hospital - Department of Rheumatology and Immunology, Xinjiang Medical University - First Affiliated Hospital, People’s Hospital of Guangxi Zhuang Autonomous Region, Inner Mongolia University, Jilin University (JLU) - First Affiliated Hospital, Soochow University - First Affiliated Hospital, Inner Mongolia University of Science and Technology, Shandong First Medical University - Shandong Provincial Hospital, University of Science and Technology of China (USTC) - Anhui Provincial Hospital, Sun Yat-sen University (SYSU) - School of Medicine, Qinghai University - Qinghai University Affiliated Hospital, Yangzhou University - Northern Jiangsu People's Hospital, Nantong University - Affiliated Hospital, Guangxi Medical University - Fifth Affiliated Hospital, Sun Yat-sen University (SYSU) - Department of Rheumatology, Nanchang University - Jiangxi Provincial People’s Hospital, Xiamen University - Department of Rheumatology and Clinical Immunology, Shandong University - Linyi People's Hospital, Peking University - Beijing Jishuitan Hospital, Genor Biopharma Co., Ltd. - Department of Biometrics, Genor Biopharma Co., Ltd. - Department of Biometrics and Peking University - Department of Rheumatology and Immunology
Downloads 33 (999,183)

Abstract:

Loading...

rheumatoid arthritis; infliximab; biosimilar

6.

Efficacy and Safety of Mufemilast in Patients with Behçet's Syndrome: A Phase 2, Double-Blind, Placebo-Controlled Trial

Number of pages: 30 Posted: 10 Mar 2025
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Tongji University, Wenzhou Medical University, Xiamen University, Xuzhou Medical University, Xuzhou Medical University, Peking University - Department of Rheumatology and Clinical Immunology, Government of the People's Republic of China - Beijing Hospital, Sun Yat-sen University (SYSU) - Department of Rheumatology, Sun Yat-sen University (SYSU) - Sun Yat-sen Memorial Hospital, Zhejiang University, Zhejiang University, People's Hospital of Xinjiang Uygur Autonomous Region, Shandong University - Linyi People's Hospital, Zhengzhou University - First Affiliated Hospital, Anhui Provincial Hospital, Fudan University - Zhongshan Hospital, Soochow University, Capital Medical University, Jilin Province People’s Hospital, Jilin Province People’s Hospital, The University of Hong Kong - Shenzhen Hospital, Baotou Medical College - First Affiliated Hospital, Fudan University, Fudan University, Nanjing Medical University - Jiangsu Province Hospital, Jilin University, Pingxiang People's Hospital, Hangzhou Medical College - Zhejiang Provincial People's Hospital, Chengdu Medical College, Ganzhou Hemay Pharmaceutical Co., Ltd, Ganzhou Hemay Pharmaceutical Co., Ltd and Peking University - Department of Rheumatology and Immunology
Downloads 32 (1,009,756)

Abstract:

Loading...

Phosphodiesterase 4 inhibitor, Behçet's syndrome, Mufemilast, RCT